Misregulation of pre-mRNA alternative splicing in cancer

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• Alternative splicing of mRNA precursors generates diverse protein isoforms crucial for complex tissue function.
• Dysregulation of alternative splicing in cancer leads to aberrant proteins that promote tumorigenesis.
• Cancer cells exploit alternative splicing to acquire altered protein functions supporting tumor development.

Purpose of the Study:

• To discuss the misregulation of alternative splicing in cancer.
• To highlight splicing events affected by regulatory splicing factors.
• To review recent findings on mutations within the splicing machinery in cancer.

Main Methods:

• Review of current literature on alternative splicing in cancer.
• Focus on deregulation of regulatory splicing factors.
• Analysis of studies identifying mutations in splicing machinery components.

Main Results:

• Aberrant mRNA splicing produces aberrant proteins contributing to tumorigenesis.
• Altered cellular concentrations of regulatory splicing factors are a major mechanism of misregulation.
• Mutations in core splicing machinery components also drive splicing misregulation in cancer.

Conclusions:

• Aberrant protein production via alternative splicing is a significant factor in cancer.
• Dysregulation of splicing factors and mutations in splicing machinery are key drivers of cancer-related splicing errors.
• Understanding these misregulation mechanisms may identify novel therapeutic targets for cancer treatment.